Safety of NNC 0123-0000-0338 in Healthy Subjects

NCT01334034 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: NNC 0123-0000-0338
DRUG: placebo
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S